Literature DB >> 2972274

Two populations of complement factor H differ in their ability to bind to cell surfaces.

J Ripoche1, A Erdei, D Gilbert, A Al Salihi, R B Sim, M Fontaine.   

Abstract

Using hydrophobic affinity chromatography on phenyl-Sepharose, human complement factor H can be separated into two subpopulations, phi 1 and phi 2. Although phi 1 and phi 2 are known to differ in their aggregation properties under non-physiological low ionic strength conditions, no difference in aggregation state was detected under the conditions used for cell-binding experiments. We have investigated these two subpopulations further to determine whether functional differences exist between them. The subpopulation phi 2 was found to bind specifically and saturably to the surface of Raji cells. The binding of the other subpopulation, phi 1, was low, and essentially non-specific. A monoclonal anti-factor H antibody, BGH-1, was raised which recognizes preferentially the phi 2 subpopulation and inhibits the binding of factor H to cell surfaces.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972274      PMCID: PMC1149322          DOI: 10.1042/bj2530475

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril.

Authors:  M A Markwell; C F Fox
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes.

Authors:  C A Sunderland; W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1979-02       Impact factor: 5.532

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

9.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.

Authors:  J D Lambris; G D Ross
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  13 in total

1.  Membrane-associated complement factor H on lymphoblastoid cell lines Raji expresses a co-factor activity for the factor I-mediated cleavage of C3b.

Authors:  M J Demares
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

Review 2.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

3.  The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.

Authors:  M Oppermann; T Manuelian; M Józsi; E Brandt; T S Jokiranta; S Heinen; S Meri; C Skerka; O Götze; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

4.  Identification of human complement factor H as a chemotactic protein for monocytes.

Authors:  K Nabil; B Rihn; M C Jaurand; J M Vignaud; J Ripoche; Y Martinet; N Martinet
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity.

Authors:  J Hellwage; S Kühn; P F Zipfel
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  Identification and characterization of a major bovine serum tyrosine-O-sulfate-binding protein as a complement factor H.

Authors:  Y Sakakibara; M Suiko; P H Fernando; T Ohashi; M C Liu
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

7.  Complement activation by phospholipids: the interplay of factor H and C1q.

Authors:  Lee Aun Tan; Bingbin Yu; Francis C J Sim; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

8.  Identification of human complement Factor H as a ligand for L-selectin.

Authors:  R Malhotra; M Ward; R B Sim; M I Bird
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

Review 9.  Outer surface protein polymorphisms linked to host-spirochete association in Lyme borreliae.

Authors:  Danielle M Tufts; Thomas M Hart; Grace F Chen; Sergios-Orestis Kolokotronis; Maria A Diuk-Wasser; Yi-Pin Lin
Journal:  Mol Microbiol       Date:  2019-02-27       Impact factor: 3.501

Review 10.  Complement factor H: using atomic resolution structure to illuminate disease mechanisms.

Authors:  Paul N Barlow; Gregory S Hageman; Susan M Lea
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.